Posted by
Obesity Could Worsen MS Disability

Obesity Could Worsen MS Disability

Latest Neurology News WEDNESDAY, June 12, 2019 (HealthDay News) — Obesity can worsen multiple sclerosis symptoms, researchers say. Their study involved 140 patients with the relapsing-remitting form of MS, which means patients have periods of attacks (relapses), followed by periods of remission with no or few symptoms. The researchers found that obesity at the time […]

Posted by
Emgality Receives First FDA Approval for Treating Cluster Headache

Emgality Receives First FDA Approval for Treating Cluster Headache

Latest Migraine News TUESDAY, June 4, 2019 (HealthDay News) — The U.S. Food and Drug Administration granted Emgality (galcanezumab-gnlm) solution the first approval for treating episodic cluster headache, the agency announced yesterday. Previously approved for preventive treatment of migraine in adults, Emgality is administered through patient self-injection. The recommended dosage of Emgality for treatment of […]

Posted by
Opioid Misuse, Binge Drinking Often Go Hand in Hand

Opioid Misuse, Binge Drinking Often Go Hand in Hand

Latest Mental Health News TUESDAY, June 11, 2019 (HealthDay News) — Of the more than 4 million Americans who misuse prescription opioids, more than half also binge drink, according to the U.S. Centers for Disease Control and Prevention. Put another way, people who binge drink are two times more likely to misuse opioids than non-drinkers, […]

Posted by
1 in 5 People Living in Conflict Areas Has a Mental Health Problem

1 in 5 People Living in Conflict Areas Has a Mental Health Problem

Latest Mental Health News WEDNESDAY, June 12, 2019 (HealthDay News) — About 22% of people who live in conflict areas suffer from mental health problems, a new study review finds. Common problems include depression, anxiety, post-traumatic stress disorder, bipolar disorder or schizophrenia, according to the World Health Organization. About 9% have a moderate to severe […]

Posted by
esketamine (Spravato)

esketamine (Spravato)

What is esketamine (Spravato), and how is it used? Spravato is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. Spravato is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if Spravato is safe or effective as an anesthetic […]

Posted by
‘Dad Shaming’ Is Real, Survey Shows

‘Dad Shaming’ Is Real, Survey Shows

Latest Healthy Kids News WEDNESDAY, June 12, 2019 (HealthDay News) — It’s not just Moms: Just ahead of Father’s Day, a new survey finds that about half of American dads say they’ve been criticized about their parenting styles. The way they enforced discipline topped the list of things naysayers called them to task on, with […]

Posted by
Marketing OK’d for Device to Help Reduce IBS Symptoms in Adolescents

Marketing OK’d for Device to Help Reduce IBS Symptoms in Adolescents

Latest Healthy Kids News TUESDAY, June 11, 2019 (HealthDay News) — The IB-Stim has received marketing approval from the U.S. Food and Drug Administration as the first medical device used to help alleviate functional abdominal pain in 11- to 18-year-old patients with irritable bowel syndrome (IBS), the agency announced Friday. The prescription-only device is composed […]

Posted by
Zerbaxa Approved for Hospital-Acquired Bacterial Pneumonia

Zerbaxa Approved for Hospital-Acquired Bacterial Pneumonia

Latest Infectious Disease News TUESDAY, June 11, 2019 (HealthDay News) — Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older, the U.S. Food and Drug Administration announced yesterday. In 2014, the FDA first approved Zerbaxa for […]